Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd. (a foreign private issuer) for the month of December 2019, specifically dated December 30, 2019. The filing addresses a corporate governance event regarding a special general meeting of shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The primary material event disclosed is the adjournment of a special general meeting of shareholders originally convened on December 30, 2019. The meeting failed to achieve a quorum. Consequently, the meeting was rescheduled to Monday, January 6, 2020, at 11:00 a.m. (Israel Time). The location was set at the offices of the Company's legal counsel in Bnei Brak. No changes were made to the proposals to be voted on, and the proxy statement remains unchanged.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, or specific business risks. The only contingency noted is the procedural requirement to reconvene the shareholder meeting to achieve a quorum.
Key Facts for Investor Verification
- The special shareholder meeting scheduled for December 30, 2019, was adjourned due to a lack of quorum.
- The rescheduled meeting date is January 6, 2020.
- The proposals for shareholder vote remain unchanged from the original proxy statement.
- This filing does not contain financial performance data.